Chandonium iodide

Drug Profile

Chandonium iodide

Alternative Names: Candocuronium iodide; HS 310

Latest Information Update: 30 Oct 2000

Price : $50

At a glance

  • Originator Central Drug Research Institute
  • Developer Central Drug Research Institute; Nonindustrial source; Ranbaxy Laboratories
  • Class Muscle relaxants
  • Mechanism of Action Acetylcholine inhibitors; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Muscle hypertonia

Most Recent Events

  • 30 Oct 2000 Discontinued-registered for Hypertonia in India (IV-injection)
  • 25 Mar 1999 No-Development-Reported for Hypertonia in India (IV-injection)
  • 05 Dec 1995 Registered for Hypertonia in India (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top